Results 111 to 120 of about 172,233 (314)

Extended anticoagulation after venous thromboembolism: should it be done?

open access: yesTherapeutic Advances in Respiratory Disease, 2019
Most physicians understand venous thromboembolism (VTE) to be an acute and time-limited disease. However, pathophysiological and epidemiological data suggest that in most patients VTE recurrence risk is not resolved after the first 6 months of ...
Caio J. Fernandes   +5 more
doaj   +1 more source

Creating an interprofessional guideline to support patients receiving oral anticoagulation therapy: a Delphi exercise

open access: yes, 2019
Background Oral anticoagulation therapy has proven beneficial impact on the prevention of thromboembolic events. However, the use of antocoagulatns also increases the risk of bleeds.
Van den Bemt, Bart J. F.   +12 more
core   +1 more source

Outpatient Anticoagulation Management

open access: yes, 2021
Objectives Warfarin Management Anticoagulation Module in Epic Brief summary of Direct Oral Anticoagulants (DOACs) Brief Perioperative Anticoagulation ...
du Breuil, MD, Anne
core  

Long‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1237-1245, April 2025.
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri   +12 more
wiley   +1 more source

Anticoagulation therapy could improve the restoration of sinus rhythm and spontaneous circulation in hospital patients with CPR

open access: yesJournal of International Medical Research, 2019
Objective To analyse the role of anticoagulation therapy in cardiopulmonary resuscitation (CPR) following an in-hospital cardiac arrest. Methods This single-centre retrospective cohort study enrolled patients treated with in-hospital CPR that met the ...
Hai Wang   +6 more
doaj   +1 more source

Anticoagulation in the Elderly

open access: yes, 2010
Management of anticoagulation in elderly patients represents a particularly challenging issue. Indeed, this patient population is at high thromboembolic risk, but also at high hemorrhagic risk. Assessment of the benefit-risk balance of anticoagulation is
Robert-Ebadi, Helia   +3 more
core   +1 more source

Connecting the dots: A narrative review of the relationship between heart failure and cognitive impairment

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1119-1131, April 2025.
Abstract Large clinical data underscore that heart failure is independently associated to an increased risk of negative cognitive outcome and dementia. Emerging evidence suggests that cerebral hypoperfusion, stemming from reduced cardiac output and vascular pathology, may contribute to the largely overlapping vascular dementia and Alzheimer's disease ...
Mauro Massussi   +6 more
wiley   +1 more source

A Modern Pharmacological Approach to Anticoagulation

open access: yes
This literature review examines the evolution, mechanisms, and clinical applications of anticoagulant therapies. It is focused on comparing traditional agents like warfarin and heparins with modern direct oral anticoagulants (DOACs).
Gammoh, Nasser
core  

Anticoagulation and Reversal Drugs

open access: yes, 2018
Management of anticoagulation, is a common practice. This chapter discusses best approaches, heparin choices, and safety issues. Anticoagulation is required in immobilized patients in the neurosciences intensive care unit to prevent deep venous ...
Sarah L. Clark, Eelco F. M. Wijdicks
core   +1 more source

Cardiovascular toxicity induced by TKIs in patients with chronic myeloid leukaemia: Are women and men different?

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1447-1454, April 2025.
This study analyzes 148 patients (66 women and 82 men) with chronic myeloid leukemia treated with tyrosine kinase inhibitors, focusing on cardiovascular adverse events. The risk assessment, performed using the HFA/ICOS score, reveals sex‐specific differences: venous thrombosis is more common in women, while arterial thrombosis predominates in men.
Cristina Madaudo   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy